Russell Investments Group, Ltd. Revance Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 198 shares of RVNC stock, worth $508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
198
Previous 203 2.46%
Holding current value
$508
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$2.57 - $2.57 $12 - $12
-5 Reduced 2.46%
198 $0
Q2 2024

Aug 08, 2024
BUY
$2.34 - $4.73 $84 - $170
36 Added 21.56%
203 $0
Q1 2024

May 08, 2024
BUY
$4.65 - $9.31 $776 - $1,554
167 New
167 $0
Q3 2023

Nov 13, 2023
SELL
$11.47 - $25.07 $670,914 - $1.47 Million
-58,493 Reduced 99.69%
182 $2,000
Q2 2023

Aug 10, 2023
BUY
$24.7 - $37.61 $747,693 - $1.14 Million
30,271 Added 106.57%
58,675 $1.49 Million
Q1 2023

May 09, 2023
SELL
$18.36 - $35.27 $938,085 - $1.8 Million
-51,094 Reduced 64.27%
28,404 $914,000
Q4 2022

Feb 08, 2023
SELL
$18.32 - $30.66 $1.37 Million - $2.29 Million
-74,730 Reduced 48.45%
79,498 $1.47 Million
Q3 2022

Nov 04, 2022
BUY
$14.33 - $28.47 $1.7 Million - $3.38 Million
118,685 Added 333.92%
154,228 $4.16 Million
Q2 2022

Jul 29, 2022
SELL
$11.52 - $20.4 $49,236 - $87,189
-4,274 Reduced 10.73%
35,543 $490,000
Q1 2022

May 05, 2022
SELL
$12.36 - $20.31 $144,537 - $237,505
-11,694 Reduced 22.7%
39,817 $775,000
Q4 2021

Jan 21, 2022
BUY
$12.46 - $27.87 $641,827 - $1.44 Million
51,511 New
51,511 $840,000
Q3 2021

Nov 08, 2021
SELL
$25.78 - $33.21 $150,426 - $193,780
-5,835 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$24.03 - $29.97 $140,215 - $174,874
5,835 New
5,835 $163,000
Q4 2020

Feb 08, 2021
SELL
$23.41 - $28.34 $1.22 Million - $1.48 Million
-52,050 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$23.23 - $34.3 $349,704 - $516,352
15,054 Added 40.69%
52,050 $1.31 Million
Q2 2020

Aug 05, 2020
BUY
$12.6 - $26.55 $466,149 - $982,243
36,996 New
36,996 $902,000
Q4 2019

Jan 29, 2020
SELL
$11.66 - $20.15 $138,754 - $239,784
-11,900 Closed
0 $0
Q3 2019

Nov 01, 2019
SELL
$10.22 - $14.5 $190,224 - $269,888
-18,613 Reduced 61.0%
11,900 $155,000
Q2 2019

Aug 09, 2019
BUY
$10.67 - $15.49 $325,573 - $472,646
30,513 New
30,513 $396,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email